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Abstract
The impact of increased national wealth, as measured by Gross Domestic Product (GDP), on public health is widely
understood, however an equally important but less well-acclaimed relationship exists between improvements in
health and the growth of an economy. Communicable diseases such as HIV, TB, Malaria and the Neglected Tropical
Diseases (NTDs) are impacting many of the world’s poorest and most vulnerable populations, and depressing
economic development. Sickness and disease has decreased the size and capabilities of the workforce through
impeding access to education and suppressing foreign direct investment (FDI). There is clear evidence that by
investing in health improvements a significant increase in GDP per capita can be attained in four ways: Firstly,
healthier populations are more economically productive; secondly, proactive healthcare leads to decrease in many
of the additive healthcare costs associated with lack of care (treating opportunistic infections in the case of HIV for
example); thirdly, improved health represents a real economic and developmental outcome in-and-of itself and
finally, healthcare spending capitalises on the Keynesian ‘economic multiplier’ effect. Continued under-investment
in health and health systems represent an important threat to our future global prosperity. This editorial calls for a
recognition of health as a major engine of economic growth and for commensurate investment in public health,
particularly in poor countries.
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Introduction
The argument for investing in public health initiatives
and infrastructure in poor countries as presented in this
editorial is twofold. Firstly, an increase in funding to
address easily preventable deaths in poor countries
would be consistent with our collective moral inclina-
tion. We seem however to be paralyzed by collective
and institutional decision-making that fails to reflect the
values we hold as individuals. And secondly, funds pro-
vided for public health spending in poor countries may
translate into economic gains exceeding the initial
investment.
Group decision-making: Five million drowning
About ten million children die in low-income countries,
defined as gross national income (GNI) less than USD
$1,005 using the World Bank Atlas Method, every year.
Millions of deaths are easily preventable with relatively
inexpensive medicines and simple interventions like pro-
viding access to bed nets and clean drinking water.
Furthermore, more than a thousand women die every
day from preventable causes during pregnancy and
childbirth–99% of these are in developing countries.
The list of alarming statistics goes on, but most startling
is the extent to which global death and disability from
preventable causes can be efficiently and cost-effectively
mitigated if we only had the political will to do so.
Well, what’s stopping us? We propose that despite the
recent economic crisis and the burgeoning era of auster-
ity, the primary issue is not one of scarcity of resources,
but rather a problem of collective decision-making.
As individuals, none of us would neglect to save a
child drowning in a pool of water in front of us. In fact,
when making the decision as an individual, each of us is
likely to make considerable personal sacrifices in order
to save the life of that child. Making that same decision
as a group however–to decide as the collective two bil-
lion upper-middle and high income people living on the
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needed to save the greater than five million children
that die of preventable causes every year, is more chal-
lenging. There seem to be important differences in the
way we make prioritize and decisions as individuals and
the way we make decisions as a group.
Broadly speaking, humans subdivide into a myriad of
groups: countries, gender groups, races, religious affilia-
tions, cultural and socio-economic strata, and the like. At
any one time, an individual is a member of multiple
groups, each with an agenda and set of associated
demands driven by incentives. Politicians, to survive the
next election cycle, are incentivized to spend and allocate
resources in such a way as to get re-elected by the collec-
tive group. Business executives are incentivized to maxi-
mize the utility of their company shareholders to maintain
their employment and income. Academics are often incen-
tivized to align their research focus with the priorities of
the main funding organizations in their respective fields.
And the majority, despite having genuinely altruistic
impulses, engage in collective thought suppression, and
the concern for children suffering in “remote places” is
lost in the incessant pace and priorities of daily life.
And so it is that, despite being predominately good
and empathetic individuals, we are unable to translate
that individual impulse and unquestioning self-sacrifice
to save a child dying in front of us into the scale of
empathy and action that needs to be taken by us as a
group. A lack of access to capital or funding is not the
main driver towards this global issue, while many
assume that is the root cause. The coordination of our
collective decision making to ensure that it reflects the
sum of our individual values is what is lacking. Collec-
tively we do not prioritize health, even as our moral
compass directs us towards investing in health and a
positive correlation between healthcare expenditure and
GDP has been demonstrated time and again.
Healthcare funding and economic gains
In the words of Robert F. Kennedy, GNP “does not
allow for the health of our children, the quality of their
education, or the joy of their play. It does not include
the beauty of our poetry or the strength of our mar-
riages; the intelligence of our public debate or the integ-
rity of our public officials.... It measures everything, in
short, except that which makes life worthwhile.” The
pain associated with the loss of a loved one and the suf-
fering associated with illness is difficult to quantify and
so is mostly understated in the discussion surrounding
the economic benefit of investing in health [1]. While
the positive effect that improved health on the GDP of
developing countries will be discussed in more detail
below, we assert that combating disease should also be
recognized as an economic end in-and-of itself [2].
In the context of the recent global financial crisis and
subsequent austerity measures, investment in develop-
ment by multilateral donors and donor countries needs
to be prudent and focus on value for money. A ten-
dency to cut back on spending on health in poor coun-
tries has translated into major budgetary cuts at the
World Health Organization, the Global Fund, PEPFAR
and other major donor agencies. The cancellation of
The Global Fund to Fight Aids, Tuberculosis, and
Malaria (GFATM) round 11 funding for example will
have a clear and predictable impact on access to health-
care for millions of people in poor countries. A less
obvious effect however will be the long-term impact on
economic growth and poverty reduction in those coun-
tries. In this editorial we argue for an increased aware-
ness of the positive effect of investing in health on the
economic development.
The interconnectedness of the global economy
extends far deeper than the superficial realm of trade
and industry, and encompasses an interdependent ecol-
ogy of our social, political, demographic and physical
reality. Health and wellbeing forms an integral compo-
nent of that ecology, and the promotion of health in
developing countries represents more than just an
opportunity to improve the physical lives of the poor,
but indeed forms an essential rung without which our
climb to global prosperity and security will be logisti-
cally impractical, economically inefficient and morally
indefensible.
Economic growth and health
Economic growth and the financial prosperity of a
nation are proven to have a positive effect on population
health. The causative paths that lead from increased
wealth to improvements in health are well understood
and broadly recognised. Populations with greater eco-
nomic opportunities tend to have ready access to quality
healthcare, less exposure to environmental hazards, bet-
ter access to clean water, and improved opportunities to
develop better preventative behaviour patterns [3]. This
is perhaps most starkly illustrated by the changes seen
in life expectancy following the industrial revolution,
and the more recent improvements in child survival in
West Africa.
While being richer does lead to health improvements,
it is also true that there is a causative relationship in the
other direction too. Health improvements lead to
increased wealth and poverty reduction in four ways:
Firstly, healthier populations are more economically pro-
ductive; secondly, proactive healthcare leads to decrease
in many of the additive healthcare costs associated with
lack of care (treating opportunistic infections in the case
of HIV for example); thirdly, improved health represents
a real economic and developmental outcome in-and-of
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Keynesian ‘economic multiplier’ effect.
Employed healthcare workers spend their salaries on
goods and services across multiple sectors of the econ-
omy, and public sector healthcare expenditures are
often spent purchasing healthcare equipment and other
goods and services from the private sector. The recipi-
ents of this spending, in turn, spend money across mul-
tiple sectors in the economy, and so on. Ultimately, this
leads to an increase in the aggregate demand in the
economy as a whole; this is particularly powerful if the
original money comes from an outside source, like a
multilateral donor. It is worth noting that this economic
multiplier effect is lost or reduced where donor fund
restrictions are in place, requiring that a significant por-
tion of the donor funds be spent on goods and services
provided by suppliers from the donor country. In the
case of the Mozambique floods in 2000, medical volun-
teers had to buy Harley Davidson motorbikes, as these
w e r et h eo n l yU S - m a d eb i k e st h a tw e r ea v a i l a b l ea t
short notice [4]. Donor fund restrictions might be signif-
icantly reduced as donor countries increasingly recog-
nise the potential of both providing immediate aid and
contributing to the increase in aggregate demand within
the local economy within which they are working.
This bidirectional causative relationship between eco-
nomic growth and health improvement presents an
opportunity for a self-enforcing spiral that perpetuates
itself either upwards or downwards. Missed opportunities
to invest in cost-effective measures to combat disease at
a population level should therefore be recognized as a
major threat to health and development in general.
In the USA it has been estimated that the increase in
life expectancy between 1970 and 2000 contributed an
additional USD 3.2 trillion per year to the national
economy (after accounting for increased healthcare
costs during that period) [5]. In fact half of the overall
economic growth in the USA during the last century
can be attributed to improvements in health [6], as for
every additional year of education attained through
improved health status, a 15% higher starting wage and
a doubling of the rate of subsequent salary increase was
attained [3]. In poor countries, a 40% increase in life
expectancy is associated with a 1.4% increase in GDP
per capita, and malnutrition world-wide impacts global
GDP negatively by up to 4.7% [7]. Half the difference
between the rate of economic growth of the least devel-
oped nations in Africa and that of the high-growth
countries of East Asia can be ascribed to a combination
of disease, demography and geography [3].
Child mortality and human capital
In poor countries, improvements in child mortality rates
ultimately result in a reduced birth rate, as families no
longer perceive the need to compensate for high infant
mortality by having more children. This translates into a
higher parental investment per child in health and edu-
cation [7]. Importantly, reduced child mortality also cir-
cumvents the economic losses associated with having no
return on the investment in a child’s education in the
form of economically productive activity when the child
becomes an adult. This was recognized as far back as
1842 when Sir Edwin Chadwick argued in his report on
The Sanitary Condition of the Labouring Population that
investment in sanitation would reduce economic losses
created by the early death of poor children [3].
The output of human capital can be thought of as a
function of productive time; it has been shown that the
economic gains from improved health equal or exceed
those due to an increase in education and on-the-job
training [3]. The Nobel Laureate Theodore Schultz
states that human capital is “vastly larger than all other
forms of wealth taken together” [8]. Importantly, for
many poor people, their only asset (for economic pro-
ductivity) is their body and the economic shock asso-
ciated with illness can drive them into abject poverty
[7].
Neglected tropical diseases
One of the most glaring opportunities for exploiting the
relationship between investing in health and economic
development is that of investing in neglected tropical
diseases (NTDs), which include 7 helminth infections
(hookworm, trichuriasis, ascariasis, schistosomiasis and
dracunculiasis, onchocerciasis and lymphatic filariasis), 3
protozoan infections: (leishmaniasis, trypanosomiasis
and Chagas’ disease) and 3 bacterial infections (leprosy,
trachoma and Buruli ulcer). Many of the names of these
pathogens may be unfamiliar to the reader, but collec-
tively these diseases contribute toward a large propor-
tion of the burden of disease in poor countries, and
significantly impact economic growth and development
in countries where they are endemic.
More than a million children in Africa are “polyparasi-
tized”, infected with both malaria and a combination of
these NTDs [9], leading to lower school attendance,
lethargy and impaired attention as well as having indir-
ect (though malabsorption of nutrients and iron-defi-
ciency anaemia) and direct effects on the brain [10].
Schistosomiasis is associated with poor short-term
memory and slower reaction times in children [11]. The
eroded economic opportunities for these children mani-
fests in an estimated drop in later income by as much
as 17% [12]. For the equivalent of just two days of Pen-
tagon spending (about USD 3 billion at the time of writ-
ing) a year, comprehensive Africa-wide control of both
malaria and the neglected tropical diseases (NCDs)
could be achieved [9].
Martin et al. Globalization and Health 2012, 8:8
http://www.globalizationandhealth.com/content/8/1/8
Page 3 of 4HIV, TB and malaria
The Global Fund, together with PEPFAR, UNITAID,
CHAI, GAVI, the World Bank, the World Health Orga-
nization (WHO) and others have made significant
inroads toward making treatment for these diseases
both available and affordable. The goal of the WHO,
UNIAID and UNICEF to virtually eliminate Mother to
Child Transmission (MTCT) of HIV by 2015 illustrates
the level of global commitment to improve the health of
the poor. However, the combined research into new
treatments for these diseases that represent over 90% of
the global burden of disease still amounts to less than
10% of the global investment in health research.
A 10% reduction of malaria in endemic areas has been
shown to be associated with a 0.3% increase in eco-
nomic growth [13] while the direct and indirect costs of
malaria in sub-Saharan Africa consume about 0.6% of
the GDP in the region [14]. Treatment costs for an
existing cohort of 3.5 million HIV positive patients on
ART (based on 2009 prices) for the next 10 years would
cost about $14.2 billion but is expected to have a net
economic benefit of between $12 billion and $34 billion
through increased productivity, averted orphan care,
deferred medical treatment for opportunistic infections
and end of life care [15].
Conclusion
To divert public spending in poor countries from health
with the belief that if these nation becomes prosperous,
their health problems will take care of themselves, is a
mistake. Under investment in health and health systems
represent an important threat to our future global pros-
perity. This paper calls for a recognition of health as a
major engine of economic growth and for commensu-
rate investment in public health, particularly in poor
countries.
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